Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

AM Rx vs HealthHub

AM Rx
Graded #491

Lower grade

vs+6.399999999999999
HealthHub
Graded #425

Higher grade

The verdict

HealthHub takes it — 56/100 to 49.6/100.

HealthHub grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. HealthHub is a LegitScript-certified telehealth platform offering compounded semaglutide and tirzepatide in oral dissolving tablet (ODT) form — a rare direct-to-consumer format.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAM Rx +5
50
45
Dose & formulationAM Rx +14
65
51
Clinical oversightHealthHub +34
41
75
Labs & monitoringHealthHub +3
49
52
FulfillmentHealthHub +3
58
61
Contract termsHealthHub +35
20
55
AM Rx · left barHealthHub · right bar

The numbers

MetricAM RxHealthHub
WeighScore49.6/10056/100
GradeCC
Scorecard rank#491#425
Semaglutide$151/mo (quarterly plan, plus a separate fee, compounded)Not disclosed
TirzepatideNot disclosedNot disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyYes
AM Rx

Graded #491 · C

Strengths

  • Insurance coordination for brand-name GLP-1s — as low as $25/mo
  • All four major brand-name GLP-1s available (Ozempic, Wegovy, Zepbound, Mounjaro)
  • HSA and FSA accepted
  • Video visits available with providers averaging 10+ years' experience
  • Compounded semaglutide from $151/mo on the quarterly plan

Where it loses points

  • Active FTC/DOJ lawsuit over deceptive billing and subscription practices
  • Novo Nordisk false-advertising lawsuit (Aug 2025)
  • Parent company Zealthy holds a BBB D- rating with 2,370+ complaints
  • Trustpilot 2.0/5, with 85% one-star reviews citing billing disputes and unreachable support
  • FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database
HealthHub

Graded #425 · C

Strengths

  • LegitScript Certified with a working verification link
  • Six named pharmacy partners with city/state: AnazaoHealth (FL), Tailor Made (KY), Redrock (UT), Professional Arts (LA), Perfect RX (TX), Vios (MI)
  • Oral dissolving tablet (ODT) form for both semaglutide and tirzepatide — rare in the DTC market
  • No subscription required — lower commitment than auto-renewal competitors
  • Cancellation policy linked publicly

Where it loses points

  • Per-drug pricing isn't shown — gated behind signup
  • Named medical director not disclosed — only a generic 'board-certified providers' claim
  • Corporate legal entity not disclosed
  • Full states-served list not shown — only testimonial cities (Austin, Miami, Denver)
  • 503A vs 503B status not stated per pharmacy

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard